Boulet Jacinthe, Myers Jonathan, Christle Jeffrey W, Arena Ross, Kaminsky Leonard, Nozza Anna, Abella Joshua, White Michel
Division of Cardiology, Department of Medicine, Université de Montréal, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec, Canada H1T 1C8.
Cardiology Division, Veterans Affairs Palo Alto Health Care System/Stanford University, Palo Alto, CA 94304, USA.
Eur Heart J Open. 2024 Dec 17;5(1):oeae104. doi: 10.1093/ehjopen/oeae104. eCollection 2025 Jan.
To better characterize functional consequences of the presence of COPD on cardiorespiratory fitness in patients with HF.
Patients with any clinical indication for cardiopulmonary exercise testing (CPET) were included in the international FRIEND registry. Diagnosis of COPD was confirmed by a ratio of forced expiratory volume in 1 s and forced vital capacity (FEV/FVC) < 0.70. HF was diagnosed in the presence of symptoms and signs of HF. A total of 10 957 patients were divided into four groups: patients without HF or COPD ( = 8963), patients with HF ( = 852) or COPD ( 991) alone, and patients with both HF and COPD ( = 151). Maximal workload was the lowest in patients with both HF and COPD [78.09 (95% CI: 72.92, 83.64 watts)], and all pairwise comparisons with adjusted < 0.05 between groups were statistically significant. Patients with both HF and COPD yielded the lowest PETCO values [31.80 (95% CI: 31.00, 32.60)] mmHg and exhibited a higher VE/VCO slope compared with HF (36.73 (95% CI: 35.78, 37.68) vs. 33.91 (95% CI: 33.50, 34.33 units, 0.0001). Peak VO was the lowest with concomitant HF and COPD 19.93 (95% CI: 18.60, 21.27) mL/kg/min and was significantly different compared with all other groups ( < 0.05).
Patients referred for CPET with COPD and concomitant HF exhibit a profound impairment in CRF compared with patients with COPD or HF alone. Early identification of pulmonary obstruction in patients with HF by more frequent usage of pulmonary function testing may contribute to providing better treatment for both COPD and HF in these high-risk individuals.
更好地描述慢性阻塞性肺疾病(COPD)的存在对心力衰竭(HF)患者心肺适能的功能影响。
有任何心肺运动试验(CPET)临床指征的患者被纳入国际FRIEND注册研究。COPD的诊断通过1秒用力呼气容积与用力肺活量之比(FEV/FVC)<0.70来确认。HF根据HF的症状和体征进行诊断。总共10957例患者被分为四组:无HF或COPD的患者(n = 8963)、单独患有HF(n = 852)或COPD(n = 991)的患者以及同时患有HF和COPD的患者(n = 151)。最大工作量在同时患有HF和COPD的患者中最低[78.09(95%置信区间:72.92,83.64瓦)],并且所有组间经校正P<0.05的两两比较均具有统计学意义。同时患有HF和COPD的患者产生的呼气末二氧化碳分压(PETCO)值最低[31.80(95%置信区间:31.00,32.60)]mmHg,并且与HF患者相比表现出更高的每分钟通气量与二氧化碳排出量斜率(36.73(95%置信区间:35.78,37.68)对33.91(95%置信区间:33.50,34.33)单位,P<0.0001)。峰值摄氧量(Peak VO)在同时患有HF和COPD时最低,为19.93(95%置信区间:18.60,21.27)mL/kg/min,并且与所有其他组相比有显著差异(P<0.05)。
与单独患有COPD或HF的患者相比,因COPD和合并HF而接受CPET检查的患者心肺储备功能(CRF)存在严重损害。通过更频繁地使用肺功能测试来早期识别HF患者的肺阻塞情况,可能有助于为这些高危个体的COPD和HF提供更好的治疗。